Loading
Latest filing published 29 Jun 2021 for BioXcel Therapeutics, Inc., €12.2M. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Our data holds just one disclosure by BioXcel LLC, dated 29 June 2021, reporting an open-market sale worth €12.2M in BioXcel Therapeutics, Inc. Further filings will be added here. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration